Literature DB >> 8270130

Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*0301-DQB1*0302 haplotype at clinical type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years. The Belgian Diabetes Registry.

C L Vandewalle1, T Decraene, F C Schuit, I H De Leeuw, D G Pipeleers, F K Gorus.   

Abstract

Demographic and biological data were collected from all Caucasian Type 1 diabetic patients (n = 279) who were recruited at clinical onset by the Belgian Diabetes Registry over 34 months. The male/female ratio was significantly higher for onset between age 20 and 40 years (2.4) than before age 20 years (1.0); no age-or sex-differences were noticed in serum fructosamine concentration. Total and high concentrations of insulin autoantibodies and islet cell antibodies were preferentially associated with the HLA DQA1*0301-DQB1*0302 susceptibility haplotype. The occurrence of both types of antibodies was also correlated, irrespective of haplotype. At onset before age 10 years, the high risk genotype DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 was more prevalent than all other DQA1-DQB1 genotypes taken together, leading to a higher prevalence of the DQA1*0301-DQB1*0302 haplotype in this age group (75%) than in the 10-39 years age group (54%). Under age 10 years, the presence of DQA1*0301-DQB1*0302 was strongly associated with insulin autoantibodies (90%) and islet cell autoantibodies (92% with 85% of high titre), whereas patients without this haplotype were less frequently positive for insulin autoantibodies (31%) or islet cell autoantibodies (38% high titre). In the group with onset at age 10-39 years, the DQA1*0301-DQB1*0302 haplotype presented a lower association with insulin autoantibodies (approximately 40%) and islet cell autoantibodies (50 to 65% high titre), prevalences which no longer differed from those in subjects lacking this haplotype.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8270130     DOI: 10.1007/bf00401060

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  45 in total

1.  Organ-specific autoantibodies in HLA genotyped insulin-dependent diabetes mellitus families.

Authors:  P Vexiau; S Helmy-Khalil; I Deschamps; J C Homberg; G Cathelineau; G Woimant; A Marcelli-Barge; J C Poirier; J Hors
Journal:  J Autoimmun       Date:  1988-06       Impact factor: 7.094

2.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

Authors:  G F Bottazzo; A Florin-Christensen; D Doniach
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

Review 3.  A unified hypothesis for the complex genetics of HLA associations with IDDM.

Authors:  G T Nepom
Journal:  Diabetes       Date:  1990-10       Impact factor: 9.461

4.  Fructosamine Test-Plus, a modified fructosamine assay evaluated.

Authors:  J Baker; P Metcalf; R Scragg; R Johnson
Journal:  Clin Chem       Date:  1991-04       Impact factor: 8.327

5.  Detection of autoantibodies against islet amyloid polypeptide in human serum. Lack of association with type 1 (insulin-dependent) diabetes mellitus, or with conditions favouring amyloid deposition in islets. The Belgian Diabetes Registry.

Authors:  F K Gorus; J C Sodoyez; D G Pipeleers; B Keymeulen; A Foriers; C F Van Schravendijk
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

6.  HLA-DQB1 alleles and absence of Asp 57 as susceptibility factors of IDDM in Finland.

Authors:  H Reijonen; J Ilonen; M Knip; H K Akerblom
Journal:  Diabetes       Date:  1991-12       Impact factor: 9.461

7.  Autoimmunity to insulin, beta cell dysfunction, and development of insulin-dependent diabetes mellitus.

Authors:  S Srikanta; A T Ricker; D K McCulloch; J S Soeldner; G S Eisenbarth; J P Palmer
Journal:  Diabetes       Date:  1986-02       Impact factor: 9.461

8.  Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers. An 8-year prospective study.

Authors:  I Deschamps; C Boitard; J Hors; M Busson; A Marcelli-Barge; A Mogenet; J J Robert
Journal:  Diabetologia       Date:  1992-10       Impact factor: 10.122

9.  Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus.

Authors:  S Caillat-Zucman; H J Garchon; J Timsit; R Assan; C Boitard; I Djilali-Saiah; P Bougnères; J F Bach
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

Review 10.  HLA and insulin-dependent diabetes. A protective perspective.

Authors:  M J Sheehy
Journal:  Diabetes       Date:  1992-02       Impact factor: 9.461

View more
  17 in total

1.  The prevalence of insulin autoantibodies at the onset of Type 1 diabetes is higher in males than females during adolescence.

Authors:  A J K Williams; A J Norcross; R J Dix; K M Gillespie; E A M Gale; P J Bingley
Journal:  Diabetologia       Date:  2003-09-09       Impact factor: 10.122

Review 2.  Latent autoimmune diabetes in adults (LADA).

Authors:  Ramachandra G Naik; Jerry P Palmer
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

Review 3.  Autoimmune diabetes: more than just one flavor?

Authors:  H K Chiu; J P Palmer
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

Review 4.  Influence of type 1 diabetes genes on disease progression: similarities and differences between countries.

Authors:  Johanna Lempainen; Jorma Ilonen
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

5.  Age-dependent HLA genetic heterogeneity of IDDM in Japanese patients.

Authors:  T Awata; R Hagura; T Urakami; Y Kanazawa
Journal:  Diabetologia       Date:  1995-06       Impact factor: 10.122

6.  Proinsulin levels and the proinsulin:c-peptide ratio complement autoantibody measurement for predicting type 1 diabetes.

Authors:  I Truyen; P De Pauw; P N Jørgensen; C Van Schravendijk; O Ubani; K Decochez; E Vandemeulebroucke; I Weets; R Mao; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  2005-10-07       Impact factor: 10.122

7.  Latent autoimmune diabetes in adults: A distinct but heterogeneous clinical entity.

Authors:  Bimota Nambam; Shakti Aggarwal; Anju Jain
Journal:  World J Diabetes       Date:  2010-09-15

8.  Anti-37kDa antibodies are associated with the development of IDDM in individuals with islet cell antibodies.

Authors:  J C Ongagna; C Levy-Marchal
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

9.  Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.

Authors:  E Sabbah; K Savola; P Kulmala; H Reijonen; R Veijola; P Vähäsalo; J Karjalainen; J Ilonen; H K Akerblom; M Knip
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

10.  Identification of prediabetes in first-degree relatives at intermediate risk of type I diabetes.

Authors:  I Truyen; J De Grijse; I Weets; L Kaufman; L Pipeleers; N Nanos; K Decochez; R Hilbrands; J-M Kaufman; B Keymeulen; C Mathieu; L Van Gaal; D G Pipeleers; F K Gorus
Journal:  Clin Exp Immunol       Date:  2007-05-22       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.